Ishares Iv Public Etf Performance

IMBXF Etf  USD 5.25  0.03  0.57%   
The etf retains a Market Volatility (i.e., Beta) of -0.11, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning IShares IV are expected to decrease at a much lower rate. During the bear market, IShares IV is likely to outperform the market.

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days iShares IV Public has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, IShares IV is not utilizing all of its potentials. The recent stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
Fifty Two Week Low4.6702
Fifty Two Week High4.7200
  

IShares IV Relative Risk vs. Return Landscape

If you would invest  525.00  in iShares IV Public on December 1, 2024 and sell it today you would earn a total of  0.00  from holding iShares IV Public or generate 0.0% return on investment over 90 days. iShares IV Public is currently producing 0.0022% returns and takes up 0.6669% volatility of returns over 90 trading days. Put another way, 5% of traded pink sheets are less volatile than IShares, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon IShares IV is expected to generate 0.89 times more return on investment than the market. However, the company is 1.13 times less risky than the market. It trades about 0.0 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly -0.04 per unit of risk.

IShares IV Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for IShares IV's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as iShares IV Public, and traders can use it to determine the average amount a IShares IV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = 0.0033

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMBXF

Estimated Market Risk

 0.67
  actual daily
5
95% of assets are more volatile

Expected Return

 0.0
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 0.0
  actual daily
0
Most of other assets perform better
Based on monthly moving average IShares IV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of IShares IV by adding IShares IV to a well-diversified portfolio.

About IShares IV Performance

By analyzing IShares IV's fundamental ratios, stakeholders can gain valuable insights into IShares IV's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if IShares IV has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if IShares IV has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
iShares IV Public Limited Company - iShares US Mortgage Backed Securities UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. It seeks to replicate the performance of the Barclays US Mortgage Backed Securities Index, by employing representative sampling methodology. iShares IV Public Limited Company - iShares US Mortgage Backed Securities UCITS ETF was formed on April 19, 2016 and is domiciled in Ireland. Ishares IV is traded on OTC Exchange in the United States.